Catalyst Wire Dossier Catalyst Wire Dossier

Mimeixin

Oxycodone/naloxone sustained-release
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mimeixin, covering 2025-03-27 to 2025-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain [Phase 4]

See pricing